Slides
Page 1
Third Quarter 2025 Earnings EARNINGS PRESENTATION October 29, 2025
Page 2
2 Forward Looking Statements, Non-GAAP Financial Measures, & Basis of Presentation FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopolitical events, future acquisitions, impact of trade and spending policies, the ability to execute the planned strategies, interest rate and current exchange rate impact, future prospects, shareholder value, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” "target", or “will” or other words of similar meaning, are “forward-looking statements" within the meaning of the United States federal securities laws. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: deterioration of or instability in the economy, the markets we serve, international trade policies and deteriorating trade relations with other countries, including imposition of tariffs and retaliatory tariffs between United States and China and other countries, responsive economic nationalism, trade restrictions, and enhanced regulation, impact of any prolonged government shutdown, the financial markets, geopolitical conditions and conflicts, security breaches or other disruptions of our information technology systems, supply chain constraints, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole sources of supply, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to recruit and retain key employees, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to develop and successfully market new products, software, and services and expand into new markets, the potential for improper conduct by our employees, agents or business partners, contingent liabilities relating to acquisitions and divestitures, impact of changes to tax laws, our compliance with applicable laws and regulations and changes in applicable laws and regulations, risks relating to international economic, geopolitical, including war and sanctions, legal, compliance and business factors, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, the impact of our debt obligations on our operations, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, our ability to adequately protect our intellectual property rights, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, commodity costs and surcharges, adverse effects of restructuring activities, our plans to separate into two independent, publicly-traded companies, risk related to tax treatment of our prior separations, impact of our indemnification obligation to Ralliant and Vontier, impact of changes to U.S. GAAP, labor matters, and disruptions relating to man-made and natural disasters and climate change. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2024 and Quarterly Reports on Form 10-Q for the subsequent quarters. These forward-looking statements speak only as of the date of this presentation, and Fortive does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise. NON-GAAP FINANCIAL MEASURES This presentation contains references to financial measures not presented in accordance with generally accepted accounting principles (“GAAP”). We have not reconciled forward-looking targets or outlook regarding non-GAAP measures because any corresponding GAAP measures and the reconciliations thereto would require us to make estimates or assumptions with precision about acquisitions, currency transactions, capital and other expenditures and similar adjustments during the relevant period. Information required by Regulation G with respect to historical non-GAAP financial measures are set forth in the appendix to this presentation and the "Investors" section of our website, www.fortive.com, under the heading "Financial Results". PRECISION TECHNOLOGIES SEPARATION On June 28, 2025, the Company completed the separation (the “Separation”) of its former Precision Technologies segment by distributing to Fortive shareholders on a pro rata basis all of the issued and outstanding common stock of Ralliant Corporation (“Ralliant”), the entity incorporated to hold the PT businesses. The accounting requirements for reporting Ralliant as a discontinued operation were met when the Separation was completed. Accordingly, the accompanying financial information for all periods presented reflect this business as a discontinued operation. Unless otherwise indicated, all references in this report refer to continuing operations. All growth or period changes refer to year-over-year comparisons unless otherwise stated. Forward looking financial information not otherwise presented as a range reflect assumptions underlying the midpoint of our forward-looking targets.
Page 3
3 1 Strong execution in our first quarter as new Fortive with solid performance across all key financial metrics 2 Raising FY adjusted EPS guidance to $2.63 to $2.67, reflecting strong Q3 Adj. EPS performance 3 $1B of share repurchases in Q3 underscores our commitment to disciplined capital allocation approach, with best relative equity returns as our North Star 4 Diligently executing Fortive Accelerated strategy, continued confidence in financial framework and value creation opportunity Key Messages
Page 4
4 Capital Allocation • Clear priorities to invest in organic growth, pursue accretive bolt-on M&A, return capital through share repurchases, and maintain a modest dividend • Executed $1B of share repurchases in Q3, retiring ~21M shares at an average ~$48 per share • Revamped our M&A funnel and process to reflect our different M&A strategy going forward – focused on accretive, smaller bolt-on M&A Faster, Profitable Organic Growth Powered by FBS Amplified Innovation Acceleration Commercial Acceleration Recurring Customer Value • New product velocity beginning to accelerate as a result of renewed focus on customer-centric innovation. Q3 notable product launches included: ◦ ServiceChannel SaaS R2 product release, featuring AI-powered work order insights, reduces multi-visit inefficiencies and streamlines payment solutions ◦ Fluke GFL 1500 Solar Ground Fault Locator marks further play into high- growth solar vertical and increases customer productivity • Launched new innovation studio and customer experience centers for collaboration and innovation to deepen customer relationships • Reorienting commercial strategies toward high-growth opportunities is showing signs of early success, and we are planting seeds for further acceleration: ◦ Recent commercial initiatives aimed at high-growth verticals beginning to have a positive impact on performance in North America across the portfolio ◦ Increased efforts in South Asia with an enhanced regional presence driving significant acceleration across both segments • Strengthening focus on recurring revenue growth opportunities to enhance durability: ◦ Fluke annual recurring revenue (ARR) from software and services continued pace of double-digit growth driven by software enhancements and increasing demand ◦ Fortive recurring revenue growth outpacing consolidated growth Fortive Accelerated
Page 5
5 Q3 2025 Revenue Reported Growth Core Growth $1,027M +2.3% +1.9% Adj. Gross Profit Adj. Gross Margin Adj. Gross Profit Growth (YoY) $651M 63.3% +1.4% Adj. EBITDA Adj. EBITDA Margin Adj. EBITDA Growth (YoY) $309M 30.1% +10.4% Adj. EPS Adj. EPS Growth (YoY) $0.68 +15.3% Free Cash Flow TTM Free Cash Flow TTM FCF Conversion on Adj. Net Income TTM FCF Growth $266M $922M 103% +5.5% Fortive Results Q3 2025, Continuing Operations 5 TTM = Trailing Twelve Months COMMENTARY • Core growth of ~2% reflects growth at both segments amidst dynamic market conditions; sequential improvement in North America, partially offset by macro weakness in Europe • Adjusted Gross Profit up slightly year over year; Adj. Gross Margin down slightly on tariff-related cost pressures offset by pricing and supply chain countermeasures • Adj. EBITDA grew +10% year over year, reflecting FBS-driven cost management and corporate cost optimization • Adj. EPS grew +15% year over year, driven by Adj. EBITDA growth, lower interest expense, and favorable impact of share repurchases • Trailing Twelve Month (TTM) Free Cash Flow Conversion on Adj. Net Income of >100%
Page 6
6 Q3 2025 Revenue Reported Growth Core Growth $699M +2.6% +2.2% Adj. Gross Profit Adj. Gross Margin Adj. Gross Profit Growth (YoY) $459M 65.7% +1.1% Adj. EBITDA Adj. EBITDA Margin Adj. EBITDA Growth (YoY) $242M 34.6% +6.7% Intelligent Operating Solutions Q3 2025, Continuing Operations 6 COMMENTARY • Revenue growth driven by strength in FAL software, professional instrumentation, and gas detection, partially offset by continued government pressure in construction procurement software • Adj. Gross Profit up modestly from last year, driven by revenue growth, partially offset by tariff cost pressures • Adj. EBITDA grew ~7%, driven by modest Adj. Gross Profit growth and disciplined cost management
Page 7
7 Q3 2025 Revenue Reported Growth Core Growth $328M +1.9% +1.1% Adj. Gross Profit Adj. Gross Margin Adj. Gross Profit Growth (YoY) $192M 58.4% +2.1% Adj. EBITDA Adj. EBITDA Margin Adj. EBITDA Growth (YoY) $92M 28.1% +6.6% Advanced Healthcare Solutions Q3 2025, Continuing Operations 7 COMMENTARY • Revenue growth driven by continued strength in resilient, SaaS-based healthcare software • Sequential improvement in healthcare equipment demand in North America, despite continued headwinds from healthcare policy and funding changes • Adj. Gross Profit growth in line with revenue growth; Adj. Gross Margins slightly up • Adj. EBITDA grew ~7%, driven by Adj. Gross Profit growth and lower operating costs
Page 8
8 Balance Sheet & Capital Allocation Q3 2025 Balance Sheet As of September 26, 2025 Cash and equivalents $0.4B Gross debt $3.3B Net debt $2.9B Q3 2025 TTM Adj. EBITDA $1.2B Gross Debt / Adj. EBITDA ~2.7x Net Debt / Adj. EBITDA ~2.4x Cash Flow, Continuing Operations TTM as of Q3 2025 Operating Cash Flow $1,019M Capital Expenditures $97M Free Cash Flow $922M Free Cash Flow Growth (YoY) +6% COMMENTARY • $1B capital deployed towards share repurchase in the quarter; repurchased ~21M shares at an average price of ~$48 per share • Ample capacity and flexibility to execute our capital deployment priorities, always with a disciplined focus on allocating capital based on relative risk-adjusted equity returns 8 TTM = Trailing Twelve Months.
Page 9
9 • Guidance raised by $0.10 at the midpoint, reflecting Q3 outperformance • Assumes current demand environment continues through the rest of 2025 • Includes net impact of current or known future tariffs expected through the end of the year, including China1 Adj. EPS | FY 2025 $2.63 - $2.67 Guidance As of Q3 2025, Continuing Operations 1. Assumes only tariffs currently in place as well as the escalation of US/China tariff rates of 55% and 35% on November 10, 2025.
Page 10
10 Innovating essential technologies to keep our world safe and productive Fortive Accelerated
Page 11
11 Supplemental Reconciliation Data
Page 12
12 CORE REVENUE GROWTH 12 Components of Revenue Growth Three Months Ended September 26, 2025 September 27, 2024 Intelligent Operating Solutions Advanced Healthcare Solutions Total Fortive Intelligent Operating Solutions Advanced Healthcare Solutions Total Fortive Total revenue growth (GAAP) 2.6 % 1.9 % 2.3 % 2.8 % 8.3 % 4.5 % Excluding impact of: Acquisitions and divestitures 0.5 % — % 0.3 % (0.8) % — % (0.6) % Currency exchange rates (0.9) % (0.8) % (0.7) % (0.3) % 0.9 % 0.1 % Core revenue growth (Non-GAAP) 2.2 % 1.1 % 1.9 % 1.7 % 9.2 % 4.0 %
Page 13
13 Three Months Ended September 26, 2025 Three Months Ended September 27, 2024 $ in millions Intelligent Operating Solutions Advanced Healthcare Solutions Total Fortive Intelligent Operating Solutions Advanced Healthcare Solutions Total Fortive Revenue (GAAP) $ 698.8 $ 328.3 $ 1,027.1 $ 681.3 $ 322.4 $ 1,003.7 Gross Profit (GAAP) $ 457.5 $ 191.7 $ 649.2 $ 453.7 $ 187.8 $ 641.5 Discrete Restructuring Charges 1.4 — 1.4 — — — Adjusted Gross Profit (Non-GAAP) $ 458.9 $ 191.7 $ 650.6 $ 453.7 $ 187.8 $ 641.5 Gross Profit Margin (GAAP) 65.5 % 58.4 % 63.2 % 66.6 % 58.3 % 63.9 % Adjusted Gross Profit Margin (Non-GAAP) 65.7 % 58.4 % 63.3 % 66.6 % 58.3 % 63.9 % 13 ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN
Page 14
14 ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS Three Months Ended $ in millions September 26, 2025 September 27, 2024 Revenue (GAAP) $ 1,027.1 $ 1,003.7 Net Earnings from Continuing Operations (GAAP) $ 117.0 $ 111.5 Interest expense, net 25.4 37.1 Income taxes 18.0 (2.4) Depreciation 17.6 15.8 Amortization 91.5 92.0 EBITDA from Continuing Operations (Non-GAAP) 269.5 254.0 Pretax acquisition, divestiture, and Separation related items (a) 38.3 0.1 Pretax discrete restructuring charges 2.1 — Pretax foreign currency transaction (gains) and losses related to Euro-denominated debt (0.5) — Pretax losses from equity investments — 26.2 Adjusted EBITDA from Continuing Operations (Non-GAAP) $ 309.4 $ 280.3 Net Earnings Margin from Continuing Operations (GAAP) 11.4 % 11.1 % Adjusted EBITDA Margin from Continuing Operations (Non-GAAP) 30.1 % 27.9 % (a) Includes pretax transaction costs, acquisition related fair value adjustments to inventory, integration costs, corresponding restructuring charges related to acquisitions, and certain Separation-related costs recorded in Earnings from continuing operations. The sum of the components of adjusted EBITDA may not equal due to rounding. 14
Page 15
15 Three Months Ended $ in millions September 26, 2025 September 27, 2024 Revenue (GAAP) $ 1,027.1 $ 1,003.7 Operating Profit (GAAP) $ 159.6 $ 172.0 Amortization of acquisition-related intangible assets and non-cash impairments 91.5 92.0 Acquisition, divestiture, and separation related items (a) 38.3 0.1 Discrete restructuring charges 2.1 — Adjusted Operating Profit (Non-GAAP) $ 291.5 $ 264.1 Depreciation 17.6 15.8 Other 0.3 0.4 Adjusted EBITDA from Continuing Operations (Non-GAAP) $ 309.4 $ 280.3 Operating Profit Margin (GAAP) 15.5 % 17.1 % Adjusted Operating Profit Margin (Non-GAAP) 28.4 % 26.3 % Adjusted EBITDA Margin from Continuing Operations (Non-GAAP) 30.1 % 27.9 % (a) Includes pretax transaction costs, acquisition related fair value adjustments to inventory, integration costs and corresponding restructuring charges related to acquisitions, and certain Separation-related costs recorded in Earnings from continuing operations. The sum of the components of adjusted operating profit may not equal due to rounding. 15 FORTIVE CONTINUING OPERATIONS: OPERATING PROFIT & OPERATING PROFIT MARGIN TO ADJUSTED EBITDA AND ADJUSTED MARGIN BRIDGE
Page 16
16 Three Months Ended September 26, 2025 Three Months Ended September 27, 2024 $ in millions Intelligent Operating Solutions Advanced Healthcare Solutions Corporate Total Fortive Intelligent Operating Solutions Advanced Healthcare Solutions Corporate Total Fortive Revenue (GAAP) $ 698.8 $ 328.3 $ — $ 1,027.1 $ 681.3 $ 322.4 $ — $ 1,003.7 Operating Profit (GAAP) $ 180.7 $ 42.5 $ (63.6) $ 159.6 $ 169.0 $ 36.7 $ (33.7) $ 172.0 Amortization of acquisition-related intangible assets 46.4 45.1 — 91.5 46.9 45.1 — 92.0 Acquisition, divestiture, and separation related items (a) 0.1 0.1 38.1 38.3 0.1 — — 0.1 Discrete restructuring charges 2.0 0.1 — 2.1 — — — — Adjusted Operating Profit (Non-GAAP) $ 229.2 $ 87.8 $ (25.6) $ 291.5 $ 216.0 $ 81.8 $ (33.7) $ 264.1 Depreciation 12.7 4.5 $ 10.7 $ 4.8 Adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) (Non-GAAP) $ 241.9 $ 92.3 $ 226.7 $ 86.6 Operating Profit Margin (GAAP) 25.9 % 12.9 % 15.5 % 24.8 % 11.4 % 17.1 % Adjusted Operating Profit Margin (Non-GAAP) 32.8 % 26.7 % 28.4 % 31.7 % 25.4 % 26.3 % Adjusted EBITDA Margin (Non-GAAP) 34.6 % 28.1 % 33.3 % 26.9 % (a) Includes pretax transaction costs, acquisition related fair value adjustments to inventory, integration costs, corresponding restructuring charges related to acquisitions, and certain Separation-related costs recorded in Earnings from continuing operations. The sum of the components of adjusted operating profit may not equal due to rounding. 16 SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN
Page 17
17 ADJUSTED NET EARNINGS AND ADJUSTED DILUTED NET EPS FROM CONTINUING OPERATIONS Three Months Ended $ in millions, except per share amounts September 26, 2025 September 27, 2024 Per share value Per share value Net Earnings and Net Earnings Per Share from Continuing Operations (GAAP) $ 117.0 $ 0.35 $ 111.5 $ 0.32 Pretax amortization of acquisition related intangible assets 91.5 0.27 92.0 0.26 Pretax acquisition, divestiture, and separation related items (a) 38.3 0.11 0.1 — Pretax discrete restructuring charges 2.1 0.01 — — Pretax foreign currency transaction (gains) and losses related to Euro-denominated debt (0.5) — — — Pretax losses from equity investments — — 26.2 0.07 Tax effect of the adjustments reflected above (b) (20.1) (0.06) (22.4) (0.06) Adjusted Net Earnings and Adjusted Net Earnings Per Share from Continuing Operations (Non-GAAP) $ 228.3 $ 0.68 $ 207.4 $ 0.59 Average Common Diluted Stock Outstanding (shares in millions) 333.4 352.3 (a) Includes pretax transaction costs, acquisition related fair value adjustments to inventory, integration costs, corresponding restructuring charges related to acquisitions, and certain Separation-related costs recorded in Earnings from continuing operations. (b) The loss from divestiture in 2024 had no tax impact. The tax effect of the adjustments includes all other line items above. The sum of the components of adjusted diluted net earnings per share may not equal due to rounding. 17
Page 18
18 Three Months Ended Trailing Twelve MonthsSeptember 26, 2025 June 27, 2025 March 28, 2025 December 31, 2024 Operating Cash Flows (GAAP) $ 294.7 $ 205.0 $ 191.8 $ 327.7 $ 1,019.2 Less: Purchases of property, plant & equipment (capital expenditures) (GAAP) (28.6) (25.0) (21.1) (22.6) (97.3) Free Cash Flow (Non-GAAP) $ 266.1 $ 180.0 $ 170.7 $ 305.1 $ 921.9 Adjusted Net Earnings from Continuing Operations (Non-GAAP) $ 228.3 $ 197.8 $ 191.1 $ 279.8 $ 897.0 Free Cash Flow Conversion on Adjusted Net Earnings from Continuing Operations 116.6 % 91.0 % 89.3 % 109.0 % 102.8 % Three Months Ended Trailing Twelve MonthsSeptember 27, 2024 June 28, 2024 March 29, 2024 December 31, 2023 Operating Cash Flows (GAAP) $ 304.7 $ 217.5 $ 178.6 $ 259.8 $ 960.6 Less: Purchases of property, plant & equipment (capital expenditures) (GAAP) (21.6) (19.6) (22.3) (23.4) (86.9) Free Cash Flow (Non-GAAP) $ 283.1 $ 197.9 $ 156.3 $ 236.4 $ 873.7 Adjusted Net Earnings from Continuing Operations (Non-GAAP) $ 207.4 $ 198.6 $ 164.7 $ 220.3 $ 791.0 Free Cash Flow Conversion on Adjusted Net Earnings from Continuing Operations 136.5 % 99.6 % 94.9 % 107.3 % 110.5 % FREE CASH FLOW FROM CONTINUING OPERATIONS - TRAILING TWELVE MONTHS (in millions) 18
Page 19
19 Three Months Ended Year Ended Three Months Ended Year Ended Three Months Ended $ in millions March 31, 2023 June 30, 2023 September 29, 2023 December 31, 2023 December 31, 2023 March 29, 2024 June 28, 2024 September 27, 2024 December 31, 2024 December 31, 2024 March 28, 2025 June 27, 2025 September 26, 2025 Geographic: North America $ 542.6 $ 580.6 $ 568.4 $ 600.9 $ 2,292.5 $ 562.1 $ 605.6 $ 601.7 $ 647.4 $ 2,416.8 $ 595.0 $ 607.6 $ 624.7 Asia-Pacific 184.0 186.4 175.5 181.3 727.2 194.0 177.6 177.8 183.9 733.3 185.2 175.7 181.4 Europe, Middle East, and Africa 170.1 170.2 165.8 191.4 697.5 181.0 179.9 168.1 192.1 721.1 167.4 181.1 167.9 Latin America 40.3 46.8 50.9 58.7 196.7 47.1 57.1 56.1 49.4 209.7 45.5 52.0 53.1 Total $ 937.0 $ 984.0 $ 960.6 $ 1,032.3 $ 3,913.9 $ 984.2 $ 1,020.2 $ 1,003.7 $ 1,072.8 $ 4,080.9 $ 993.1 $ 1,016.4 $ 1,027.1 End Markets: Healthcare $ 282.6 $ 305.3 $ 296.3 $ 326.7 $ 1,210.9 $ 294.2 $ 317.7 $ 315.5 $ 337.3 $ 1,264.7 $ 296.2 $ 313.4 $ 322.2 Industrial & Manufacturing 280.0 283.6 277.1 298.4 1,139.1 298.7 290.4 282.7 300.8 1,172.6 298.3 288.7 287.9 Energy & Infrastructure 156.8 159.5 160.1 157.4 633.8 162.7 164.3 157.5 175.0 659.5 165.6 167.5 166.7 Government 71.3 86.9 82.9 89.7 330.8 79.8 91.0 93.0 93.1 356.9 82.4 91.6 88.0 Retail 66.7 65.9 69.7 74.4 276.7 66.1 71.0 75.3 78.8 291.2 71.8 75.0 82.7 Other 79.6 82.8 74.5 85.7 322.6 82.7 85.8 79.7 87.8 336.0 78.8 80.2 79.6 Total $ 937.0 $ 984.0 $ 960.6 $ 1,032.3 $ 3,913.9 $ 984.2 $ 1,020.2 $ 1,003.7 $ 1,072.8 $ 4,080.9 $ 993.1 $ 1,016.4 $ 1,027.1 19 DISAGGREGATION OF REVENUE - TOTAL FORTIVE
Page 20
20 Three Months Ended Year Ended Three Months Ended Year Ended Three Months Ended $ in millions March 31, 2023 June 30, 2023 September 29, 2023 December 31, 2023 December 31, 2023 March 29, 2024 June 28, 2024 September 27, 2024 December 31, 2024 December 31, 2024 March 28, 2025 June 27, 2025 September 26, 2025 Intelligent Operating Solutions Geographic: North America $ 377.5 $ 400.4 $ 401.2 $ 413.4 $ 1,592.5 $ 390.7 $ 421.3 $ 412.8 $ 449.7 $ 1,674.5 $ 415.0 $ 421.5 $ 433.2 Asia-Pacific 118.1 116.0 105.4 108.3 447.8 126.1 111.5 109.1 109.8 456.5 119.4 107.6 111.4 Europe, Middle East, and Africa 131.8 130.0 130.5 149.2 541.5 141.6 136.0 129.5 145.9 553.0 130.6 137.9 126.3 Latin America 22.2 24.4 25.8 30.3 102.7 26.0 27.8 29.9 25.5 109.2 25.9 29.9 27.9 Total $ 649.6 $ 670.8 $ 662.9 $ 701.2 $ 2,684.5 $ 684.4 $ 696.6 $ 681.3 $ 730.9 $ 2,793.2 $ 690.9 $ 696.9 $ 698.8 End Markets: Healthcare $ 11.1 $ 11.7 $ 11.0 $ 14.7 $ 48.5 $ 11.5 $ 11.4 $ 10.6 $ 14.0 $ 47.5 $ 10.7 $ 10.9 $ 10.8 Industrial & Manufacturing 275.7 279.1 273.2 293.7 1,121.7 294.1 285.8 278.5 295.9 1,154.3 293.8 284.2 284.3 Energy & Infrastructure 156.8 159.5 160.1 157.4 633.8 162.7 164.3 157.5 175.0 659.5 165.6 167.5 166.7 Government 62.9 78.2 74.6 78.4 294.1 70.7 81.7 82.9 83.0 318.3 73.5 82.5 78.1 Retail 66.7 65.9 69.7 74.4 276.7 66.1 71.0 75.3 78.8 291.2 71.8 75.0 82.7 Other 76.4 76.4 74.3 82.6 309.7 79.3 82.4 76.5 84.2 322.4 75.5 76.8 76.2 Total $ 649.6 $ 670.8 $ 662.9 $ 701.2 $ 2,684.5 $ 684.4 $ 696.6 $ 681.3 $ 730.9 $ 2,793.2 $ 690.9 $ 696.9 $ 698.8 Advanced Healthcare Solutions Geographic: North America $ 165.1 $ 180.2 $ 167.2 $ 187.5 $ 700.0 $ 171.4 $ 184.3 $ 188.9 $ 197.7 $ 742.3 $ 180.0 $ 186.1 $ 191.5 Asia-Pacific 65.9 70.4 70.1 73.0 279.4 67.9 66.1 68.7 74.1 276.8 65.8 68.1 70.0 Europe, Middle East, and Africa 38.3 40.2 35.3 42.2 156.0 39.4 43.9 38.6 46.2 168.1 36.8 43.2 41.6 Latin America 18.1 22.4 25.1 28.4 94.0 21.1 29.3 26.2 23.9 100.5 19.6 22.1 25.2 Total $ 287.4 $ 313.2 $ 297.7 $ 331.1 $ 1,229.4 $ 299.8 $ 323.6 $ 322.4 $ 341.9 $ 1,287.7 $ 302.2 $ 319.5 $ 328.3 End Markets: Healthcare $ 271.5 $ 293.6 $ 285.3 $ 312.0 $ 1,162.4 $ 282.7 $ 306.3 $ 304.9 $ 323.3 $ 1,217.2 $ 285.5 $ 302.5 $ 311.4 Industrial & Manufacturing 4.3 4.5 3.9 4.7 17.4 4.6 4.6 4.2 4.9 18.3 4.5 4.5 3.6 Government 8.4 8.7 8.3 11.3 36.7 9.1 9.3 10.1 10.1 38.6 8.9 9.1 9.9 Other 3.2 6.4 0.2 3.1 12.9 3.4 3.4 3.2 3.6 13.6 3.3 3.4 3.4 Total $ 287.4 $ 313.2 $ 297.7 $ 331.1 $ 1,229.4 $ 299.8 $ 323.6 $ 322.4 $ 341.9 $ 1,287.7 $ 302.2 $ 319.5 $ 328.3 20 DISAGGREGATION OF REVENUE - SEGMENTS
Page 21
21